SurvivorNet on MSN

Diagnosing muscle-invasive bladder cancer: The initial work-up

When a doctor suspects bladder cancer, they will order a series of tests which may include urine tests (urinalysis or urine ...
Medscape

Sacituzumab Govitecan Plus Pembrolizumab Shows Promise for Bladder Sparing in Muscle-Invasive Cancer

Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant ...
MedPage Today on MSN

Organ-Sparing Strategy 'Promising' in Muscle-Invasive Bladder Cancer

Phase II study tested combination of sacituzumab govitecan plus pembrolizumab ...

Theralase(R) Demonstrates That X-Ray-Activated Rutherrin(R) Is Significantly More Effective than Radiation Alone in the Destruction of Muscle Invasive Bladder Cancer

Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical ...
CURE

Anktiva Plus BCG Resubmitted to FDA for Papillary Bladder Cancer

The FDA has received a new application for Anktiva plus BCG to treat BCG-unresponsive non–muscle invasive bladder cancer with ...
Fierce Pharma

Padcev-Keytruda combo aces another bladder cancer trial as MIBC landscape becomes more complex

To further complicate clinicians’ treatment decisions, Padcev-Keytruda has become the new standard of care in first-line metastatic bladder cancer, raising the possibility that some physicians might ...
Fred Hutch

Bladder Cancer Stages

The extent of the bladder cancer — how far it has spread — matters. Your care team needs to know if your cancer sits on or in the first lining of your bladder (non-muscle invasive), if it goes into ...

Blood test predicts which bladder cancer patients may safely skip surgery

Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for ...